In vivo validation studies demonstrated that varying CNOT2 levels significantly influenced tumor metastatic capacity and implicated the CCR4-NOT complex as a novel determinant of tumor cell metastatic potential [10]. This evidence concerns the gene CCR4 and neoplasm.